✦ LIBER ✦

PRS10 TREATMENT COSTS ASSOCIATED WITH COMMUNITY ACQUIRED PNEUMONIA BY COMMUNITY LEVEL OF ANTIMICROBIAL RESISTANCE

✍ Scribed by CV Asche; B Seal; C McAdam-Marx; B Crookston; R Svedja; CD Mullins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antimicrobial Resistance and Treatment o

✍ Mandell, Lionel A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 186 KB

A cost-effectiveness analysis of antimic

✍ Martin, Monique; Moore, Lee; Quilici, Sibilia; Decramer, Marc; Simoens, Steven 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 673 KB

Cost-Effectiveness of Sparfloxacin Compa

✍ Mr. Mohammad M. Najib; Dr. Gary E. Stein; Dr. Thomas F. Goss 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PRS9 THE COST-EFFECTIVENESS OF TARGETED

✍ L Moore; M Martin; S Quilici; DE Low; R Grossman; A Kureishi; M Kubin; B Jaszews 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PRS4 THE COST-EFFECTIVENESS OF DRUG THER

✍ M Martin; S Quilici; T Evers; M Kubin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Antibacterial drug resistance: implicati

✍ Metlay, Joshua P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB